Mark Jeffrey DeLong - 20 Oct 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Senior Vice President
Signature
/s/ David Watson, attorney-in-fact for Mark Delong
Issuer symbol
APLS
Transactions as of
20 Oct 2022
Net transactions value
-$11,368
Form type
4
Filing time
24 Oct 2022, 17:10:56 UTC
Previous filing
18 Aug 2022
Next filing
17 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability $11,368 -196 -0.67% $58.00 29,054 20 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares used to cover tax withholding on a Restricted Stock Unit release.